Target intelligence / Profile preview

General cellular DNA synthesis machinery

Molecular classification
Enzyme, DNA-binding protein, Multi-protein complex
01

Overview

The general cellular DNA synthesis machinery, often referred to as the replisome, is a complex multi-protein system responsible for the accurate and efficient duplication of the genome during the S phase of the cell cycle [StatPearls, 2023]. Key components of this machinery include DNA polymerases (alpha, delta, and epsilon), helicases, primases, and topoisomerases, which work in a coordinated fashion to unwind the double helix and synthesize new DNA strands [Nature Reviews Cancer, 2013]. Because rapid cell division is a hallmark of both cancer and various infectious pathogens, this machinery serves as a primary target for a wide array of therapeutic agents [NCBI, 2022]. Antimetabolites interfere with the production of nucleotide precursors, while direct inhibitors of DNA polymerase or topoisomerases disrupt the physical process of replication and can induce lethal DNA damage [StatPearls, 2023]. However, because these processes are fundamental to all dividing cells, drugs targeting this machinery often exhibit significant side effects, such as bone marrow suppression and gastrointestinal distress, due to their impact on healthy, rapidly proliferating tissues [NCBI, 2022].

Other names
DNA replication machineryReplisomeDNA synthesis pathwayDNA replication complex
02

Mechanism of action

Inhibition of nucleotide precursor synthesis (antimetabolites), direct inhibition of DNA polymerase enzymes, induction of DNA strand breaks via topoisomerase inhibition, and premature chain termination during DNA elongation [StatPearls, 2023; NCBI, 2022].

03

Biological functions

DNA replicationCell cycleDNA repairCell proliferation
04

Disease associations

CancerInfectionAutoimmune disease
05

Safety considerations

MyelosuppressionGastrointestinal toxicity (mucositis)AlopeciaGenotoxicitySecondary malignanciesTeratogenicity
06

Interacting drugs

5-Fluorouracil

9 more in the full profile.

07

Biomarkers

Ki-67PCNA (Proliferating Cell Nuclear Antigen)Thymidine kinase 1Argyrophilic nucleolar organizer regions (AgNORs)

Beyond the preview

Go deeper on General cellular DNA synthesis machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular DNA synthesis machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call